Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Inglewood, California 90301


Purpose:

The objective of this study was to describe the intraocular pressure-lowering efficacy of AL-3789 over a 24-hour period in patients with open-angle glaucoma compared to an untreated control. Patients received one treatment of AL-3789. Twenty-eight days after treatment, IOP was measured every 4 hours, beginning at 8 AM for 24 hours.


Criteria:

Inclusion Criteria: - Diagnosis of open-angle glaucoma and treated for at least 30 days prior to Screening Visit with a topical prostaglandin analog as monotherapy. - Other protocol-defined inclusion criteria may apply. Exclusion Criteria: - Pregnant, intend to become pregnant, breastfeeding. - Difference in IOP greater than 3 mm Hg between eyes at Screening Visit. - Any form of glaucoma other than open-angle glaucoma. - Other protocol-defined exclusion criteria may apply.


NCT ID:

NCT00643669


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Inglewood, California 90301
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.